Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Anti-inflammatory and antioxidant effects of Myrtus communis in ligature-induced periodontitis in rats.

Created on 19 Oct 2026

Authors

Z K Sarıtaş, F Görücü Özbek, Y Koç, I Demirkan, H H Demirel, A Bülbül, N C Karakan

Published in

Polish journal of veterinary sciences. Volume 29. Issue 3. Pages 381-390. Sep 17, 2026. Epub Sep 17, 2026.

Abstract

This study aimed to investigate the effects of Myrtus communis (MC) extract on oxidative stress, inflammation and alveolar bone loss in ligature-induced periodontitis in rats. Forty-two adult male Wistar Albino rats were randomly divided into six groups: Control (C); Periodontitis (P); Periodontitis + MC (P+GG+MC); Periodontitis + MC (P+IO+MC); Periodontitis + chlorhexidine (P+CHX); and Periodontitis + MC (P+GG+IO+MC). Myrtus communis extract (150 μg/mL, 0.5 mL) was administered via gastric gavage or spray. Chlorhexidine (0.3 mL) was administered once daily for 11 days via spray. Serum oxidative stress markers (TOS, TAS), inflammatory markers (TNF-α, IL-1β, IL-6, MMP-8, MMP-9), bone morphometry using micro-CT, and histopathological analyses (RANKL, ICD) were evaluated. The lowest ICD levels were observed in the P+CHX group, while RANKL activity was highest in the P group. TAS levels were significantly higher in the P+GG+MC group compared to the P, P+IO+MC, and P+GG+IO+MC groups, while TOS levels were highest in the P group. Bone quantity tended to be greater in the P+GG+MC group compared to other groups, whereas the bone ratio was higher in the P+CHX group. MMP-8 levels were significantly lower in the P+GG+MC group compared to all other groups. In conclusion, the data obtained indicate that Myrtus communis extract, particularly when administered systemically, may serve as an adjuvant treatment option by preventing alveolar bone loss through its antioxidant and anti-inflammatory effects.

PMID:
42894988
Bibliographic data and abstract were imported from PubMed on 19 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement